Hemera enthusiastically participated in ISCT 2024, the event organized by the International Society for Cell & Gene Therapy, held in Vancouver from May 28 to June 2. During this conference, Hemera was present in the Innovation Zone, an area dedicated to the most innovative companies in the field of cell therapies, where cutting-edge technologies were showcased.

In this context, Hemera presented the work titled “Human Regenerative Macrophages: REMaST®️ cell therapy development for clinical use,” focused on the product development and manufacturing processes, highlighting the progress and innovations characterizing REMaST®️ therapy.

ISCT 2024 brought together experts and leaders in the field, offering a platform for stimulating discussions and the exchange of innovative ideas. Our participation in this event strengthened our commitment to leading progress in the field of cell and gene therapies, paving the way for new collaborations and growth opportunities.